{"product_id":"recombinant-her2-antibody-bha17103744","title":"Recombinant HER2 Antibody","description":"\u003ch2\u003eOverview\u003c\/h2\u003e \u003cp\u003eRecombinant HER2 antibody supplied as a purified reagent for WB, IHC in Human samples. This product is a recombinant rabbit monoclonal antibody (host: Rabbit; isotype: Rabbit IgG) intended for research use only. The target is commonly annotated with cell surface, cytoplasm, nucleus localization context, which may inform staining patterns.\u003c\/p\u003e \u003ch2\u003eKey elements and design rationale\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003e\n\u003cstrong\u003eAntibody identity:\u003c\/strong\u003e Recombinant Rabbit Monoclonal; host Rabbit; isotype Rabbit IgG; clone RM228.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eFormat and purification:\u003c\/strong\u003e format: Purified; purity: Protein A purified from animal origin-free supernatant.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eSpecies reactivity (reported):\u003c\/strong\u003e Human.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eApplications (listed):\u003c\/strong\u003e WB, IHC.\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eImmunogen \/ epitope context:\u003c\/strong\u003e A peptide corresponding to the C-terminus of human c-erbB2\/HER2 was used as the immunogen for this recombinant HER2 antibody..\u003c\/li\u003e   \u003cli\u003e\n\u003cstrong\u003eLocalization:\u003c\/strong\u003e Cell surface, cytoplasm, nucleus (annotation-level guidance; cell state and isoforms can shift patterns).\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThese attributes help you align the antibody with the biological question (target state, sample type, and readout) while keeping interpretation grounded in appropriate controls.\u003c\/p\u003e \u003ch2\u003eBiological background\u003c\/h2\u003e \u003cp\u003eRecombinant HER2 is the intended antigen for this primary antibody. Reported biological context includes: This recombinant HER2 antibody reacts to Human c-erbB-2\/HER-2. It may also react to mouse or rat c-erbB-2\/HER-2, as predicted by immunogen homology. Subcellular localization information (Cell surface, cytoplasm, nucleus) can be useful when interpreting IF\/ICC patterns and selecting compartment-enriched lysates for WB.\u003c\/p\u003e \u003ch2\u003eResearch relevance and current trends\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003eSpatial and single-cell approaches: imaging-based and cytometry workflows increasingly quantify heterogeneity and relocalization rather than only bulk abundance.\u003c\/li\u003e   \u003cli\u003eInteraction-centric biology: IP-based enrichment and proteomics are widely used to define complexes, binding partners, and context-specific interactomes.\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eCommon research applications\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003eWestern blot (WB): compare relative abundance\/isoform patterns across conditions and sample types; band shifts may reflect processing or post-translational modification.\u003c\/li\u003e   \u003cli\u003eImmunohistochemistry (IHC): profile tissue and cell-type distribution in fixed specimens and evaluate spatial heterogeneity in expression.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eAcross these readouts, differences in signal intensity, localization, or complex enrichment are typically interpreted alongside sample-matched controls and independent evidence to distinguish regulation from technical variation.\u003c\/p\u003e \u003ch2\u003eNotes for experimental interpretation\u003c\/h2\u003e \u003cul\u003e   \u003cli\u003eIsoforms, cleavage products, or post-translational modifications can alter apparent molecular weight and subcellular distribution; interpret bands and staining patterns in the context of expected biology and sample preparation.\u003c\/li\u003e   \u003cli\u003eSpecies differences and epitope conservation may affect binding; use matched positive controls and orthogonal evidence when comparing across organisms.\u003c\/li\u003e   \u003cli\u003eControl concepts: include appropriate isotype and secondary-only controls (for imaging), and consider genetic perturbations (knockout\/knockdown\/overexpression) or independent antibodies targeting distinct epitopes to strengthen conclusions.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eEpitope context is defined by the immunogen description; when available, align this with known domains, PTM sites, or family homology to anticipate potential cross-reactivity patterns. As a monoclonal antibody, binding is driven by a single epitope, which can support consistent recognition but may be sensitive to epitope masking by PTMs or conformational changes.\u003c\/p\u003e \u003c!-- Sources (internal): - UniProtKB entry (P04626) — UniProt Consortium — https:\/\/www.uniprot.org\/uniprotkb\/P04626\/entry - NCBI Gene search (Recombinant HER2) — NCBI — https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=Recombinant+HER2 - Ensembl search (Recombinant HER2) — Ensembl — https:\/\/www.ensembl.org\/Multi\/Search\/Results?q=Recombinant+HER2 - PubMed search (Recombinant HER2) — NLM — https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Recombinant+HER2 - Reactome pathway search (Recombinant HER2) — Reactome — https:\/\/reactome.org\/content\/query?q=Recombinant+HER2 --\u003e","brand":"NSJ Bioreagents","offers":[{"title":"Antibody in PBS with 50% glycerol, 1% BSA and 0.09% sodium azide \/ 0.1 ml","offer_id":53043248464237,"sku":"R20258-0.1ML","price":439.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/get_image_78e9e639-8d49-4205-9935-5eef6011d05f.jpg?v=1771934405","url":"https:\/\/www.ebiohippo.com\/products\/recombinant-her2-antibody-bha17103744","provider":"BioHippo","version":"1.0","type":"link"}